Cellular Immunity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits variable immunity responses among hosts based on symptom severity. Whether immunity in recovered individuals is effective for avoiding reinfection is poorly understood. Determination of immune memory status against SARS-CoV-2 helps identify reinfection risk and vaccine efficacy. Hence, after recovery from COVID-19, evaluation of protective effectiveness and durable immunity of prior disease could be significant. Recent reports described the dynamics of SARS-CoV-2 -specific humoral and cellular responses for more than six mon...

Current COVID-19 vaccines provide robust protection against severe disease caused by both the Delta and Omicron variants

Commentary We should not force COVID vaccines on anyone when the evidence shows that naturally acquired immunity is ...

Clive Dix said the durable cellular immunity response produced by the AZ jab can potentially ‘last for life’.

PLOS ONE editors choose their favorite papers of the last 15 years.